SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007065
Filing Date
2024-05-07
Accepted
2024-05-07 16:20:40
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20240331x10q.htm   iXBRL 10-Q 1367389
2 EX-10.7 ocul-20240331xex10d7.htm EX-10.7 79262
3 EX-10.8 ocul-20240331xex10d8.htm EX-10.8 21420
4 EX-31.1 ocul-20240331xex31d1.htm EX-31.1 12027
5 EX-31.2 ocul-20240331xex31d2.htm EX-31.2 8447
6 EX-32.1 ocul-20240331xex32d1.htm EX-32.1 5018
7 EX-32.2 ocul-20240331xex32d2.htm EX-32.2 4971
  Complete submission text file 0001558370-24-007065.txt   6071021

Data Files

Seq Description Document Type Size
8 EX-101.SCH ocul-20240331.xsd EX-101.SCH 45165
9 EX-101.CAL ocul-20240331_cal.xml EX-101.CAL 45164
10 EX-101.DEF ocul-20240331_def.xml EX-101.DEF 215535
11 EX-101.LAB ocul-20240331_lab.xml EX-101.LAB 347369
12 EX-101.PRE ocul-20240331_pre.xml EX-101.PRE 320761
79 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20240331x10q_htm.xml XML 850884
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 24922288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)